Korean MFDS Grants Innovative Medical Device Designation to Kalos Medicals’ DENEX Hypertension Treatment System
Shots:
- The Innovative Medical Device Designation differentiates the designated devices in terms of improved safety and efficacy than the existing one
- The DENEX system is a short and safe procedure without any side effects associated with general anesthesia that utilizes renal denervation technology to treat hypertension
- In this technology electrodes are inserted into sympathetic nerve locations in the kidneys. The device then uses radiofrequency energy applied to the arterial wall to inactivate portions of the sympathetic nerves, resulting to be effective as an anti-hypertensive
Ref: Globenewswire | Image: Kalos Medicals
Related News:- Janssen Reports the MAA Submission of Macitentan and Tadalafil to the EMA for the Treatment of Pulmonary Arterial Hypertension
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
